Come up with a name for your new list and we'll add to it:
SERB raised a round of funding on June 09, 2017. Investors include
Charterhouse Capital Partners.
SERB is a European specialty pharmaceutical group that focuses on niche branded prescription drugs for use in areas of medicine including critical and emergency care, neurology, diagnostics, and endoc…